2021
DOI: 10.1002/alz.12398
|View full text |Cite
|
Sign up to set email alerts
|

Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A

Abstract: The Ca 2+ hypothesis for Alzheimer's disease (AD) conceives Ca 2+ dyshomeostasis as a common mechanism of AD; the cause of Ca 2+ dysregulation, however, is obscure.Meanwhile, hyperactivities of N-Methyl-D-aspartate receptors (NMDARs), the primary mediator of Ca 2+ influx, are reported in AD. GluN3A (NR3A) is an NMDAR inhibitory subunit. We hypothesize that GluN3A is critical for sustained Ca 2+ homeostasis and its deficiency is pathogenic for AD. Cellular, molecular, and functional changes were examined in adu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
26
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(26 citation statements)
references
References 116 publications
0
26
0
Order By: Relevance
“…A possible mechanism of neurodegeneration may be the activation of TRPA1 channels leading to an increased calcium influx, triggering neuronal activation on one hand and in the case of excessive function, neuronal apoptosis. This process may occur in the glutamatergic excitatory neurons of the OB and PC and-together with consecutive glutamatergic excitotoxicity-may explain the appearance of anosmia in neurodegenerative diseases (e.g., Parkinson's, Alzheimer's) [62][63][64] 5-10 years prior to the emergence of other neurological symptoms [30,31].…”
Section: Discussionmentioning
confidence: 99%
“…A possible mechanism of neurodegeneration may be the activation of TRPA1 channels leading to an increased calcium influx, triggering neuronal activation on one hand and in the case of excessive function, neuronal apoptosis. This process may occur in the glutamatergic excitatory neurons of the OB and PC and-together with consecutive glutamatergic excitotoxicity-may explain the appearance of anosmia in neurodegenerative diseases (e.g., Parkinson's, Alzheimer's) [62][63][64] 5-10 years prior to the emergence of other neurological symptoms [30,31].…”
Section: Discussionmentioning
confidence: 99%
“…Ca 2+ dysregulation is a common and pervasive pathophysiological phenomenon in AD. Zhong et al [ 27 ] hypothesized that N-methyl-D-aspartate receptor subunit (GluN3A) is essential for sustained Ca 2+ homeostasis and its deficiency is a causative factor in AD. By examining cellular, molecular and functional changes in adult/senescent GluN3A knockout (KO) mice, they concluded that chronic ‘degenerative excitotoxicity’ can lead to sporadic AD, and GluN3A is the main pathogenic factor, a lifelong moderate but sustained Ca 2+ overload is a causal pathogenic mechanism of sporadic AD.…”
Section: Pathogenesis Of Alzheimer’s Diseasementioning
confidence: 99%
“…By examining cellular, molecular and functional changes in adult/senescent GluN3A knockout (KO) mice, they concluded that chronic ‘degenerative excitotoxicity’ can lead to sporadic AD, and GluN3A is the main pathogenic factor, a lifelong moderate but sustained Ca 2+ overload is a causal pathogenic mechanism of sporadic AD. Therefore, GluN3A may be an amyloid-independent therapeutic target [ 27 ].…”
Section: Pathogenesis Of Alzheimer’s Diseasementioning
confidence: 99%
“…Accumulation of Aβ oligomers has been observed in the synapses of glutamatergic neurons in AD brains [196,197]. Although plenty of studies have demonstrated that Aβ mediates neurotoxicity by directly or indirectly regulating NMDARs [6,[198][199][200][201][202], and NMDAR antagonists can rescue Aβ-induced damage [116,203], interestingly, genetic deletion of the NMDAR subunit GluN3A results in neuropathological changes like AD, including psychological/cognitive deficits and amyloid-β/tau pathology [204]. Moreover, blocking NMDARs may reduce neurodegeneration [205].…”
Section: The N-methyl-d-aspartate Receptormentioning
confidence: 99%